כל המחקרים
גיוסשלב 3התערבותי

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

This study is checking the long-term safety of a medicine called luspatercept. It's for adults, aged 18 and over, who have blood conditions like Myelodysplastic Syndromes (MDS), Beta-thalassemia, or Myelofibrosis and have already been part of another luspatercept study. If your doctor thinks you're benefiting from luspatercept, or if you were on a placebo but could now benefit from the active medicine, you might be able to join. The main goal is to keep an eye on your health and any side effects over a long period, which could be several years, as you continue with or finish your treatment.

במבט חטוף

סטטוס
גיוס
שלב
שלב 3
נותן חסות
Celgene
יעד הרשמה
665
התחל
12 Aug 2019
השלמה משוערת
12 May 2028

על מה המחקר הזה?

This study is like a continuation for people who have already been taking part in a clinical trial for a medicine called luspatercept. Luspatercept is a treatment for certain blood conditions such as Myelodysplastic Syndromes (MDS), a type of blood cancer; Beta-thalassemia, which is an inherited blood disorder; and Myelofibrosis, where the bone marrow is replaced by scar tissue. The main purpose of this new study is to carefully watch how safe luspatercept is over a much longer period of time.

Taking part in this study means you’ll either continue receiving luspatercept if your doctor thinks it's helping you, or, if you were on a dummy treatment (placebo) in a previous study, you might switch to receiving luspatercept. If you've already finished treatment in a previous study, you might join this one for long-term health checks, to see how you are doing over many years. This helps researchers understand the full picture of the medicine's safety.

By carefully checking on participants for several years, doctors and researchers can learn a lot about any potential long-term side effects or benefits of luspatercept. This information is really important for making sure new medicines are as safe and effective as possible for everyone who might need them in the future. The study will pay close attention to your general health and any changes, including checking for any new health problems that might develop.

נקודות עיקריות

  • This study is for checking the long-term safety of luspatercept.
  • It's for people already in a luspatercept study.
  • You might continue treatment, start it, or just have long-term health checks.
  • The study involves regular visits and monitoring over several years.
  • It aims to gather important information about the medicine's effects over time.
  • Your general health and any new problems will be closely monitored.

מי עשוי להיות זכאי?

To be able to join this study, you must be at least 18 years old and already taking part in another study involving luspatercept. You also need to be willing to come to all the study appointments and follow the study's instructions.

There are a few main ways you might fit in. Firstly, if you're currently receiving luspatercept in another study and your doctor feels it’s still helping you, you might be able to continue on it in this new study. Secondly, if you were on a dummy treatment (placebo) in your previous study and it's decided that you could benefit from luspatercept, you might switch to receiving the actual medicine. Finally, if you've already finished treatment in a previous luspatercept study but are still having your health checked, you might join this study to continue those long-term health checks.

האם מחקר זה יכול להתאים לך?

ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.

  1. האם אתה בן 18 או יותר?
  2. Are you currently taking part in another study for luspatercept, or have you recently finished one?
  3. Is your doctor recommending you continue with luspatercept, start it, or continue with long-term follow-up after your previous study?
  4. Are you able and willing to attend all study appointments and follow instructions?
ענה על כל שאלה כדי לראות את התוצאה שלך.

מה כרוך בהשתתפות?

If you join this study, your journey will have different stages. There's an initial 'Transition Phase' which involves one initial check-up visit. Depending on your situation from your previous study, you will then either enter a 'Treatment Phase' or a 'Follow-up Phase'.

If you enter the 'Treatment Phase', you will continue to receive luspatercept at the same dose and schedule you were on in your previous study. After your last dose of luspatercept, you will have a '42 Day Safety Follow-up Visit' where doctors will check your health and any side effects. The 'Follow-up Phase' is much longer; doctors will keep in touch every 6 months for at least 5 years from your very first dose of luspatercept (in your original study), or for 3 years after your last dose, whichever is longer. During this long-term follow-up, they will monitor your general health and look for any new health conditions. The study will continue until all participants have completed 5 years of being in the study, including both treatment and follow-up.

סיכונים ותועלות פוטנציאליים

The main benefit of taking part in this study is that if luspatercept is helping you, you may be able to continue receiving the treatment for longer under careful medical supervision. For others, it provides ongoing health monitoring. As with any medicine, there's always a chance of side effects, and these will be closely watched by the study team. You will have regular check-ups to monitor your health. Remember, you have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

מיקומים (143)

  • Local Institution - 968
    מיקוד מאומת
    לוס אנג'לס, ארצות הברית· הושלם
  • Local Institution - 971
    מיקוד מאומת
    אוקלנד, ארצות הברית· הושלם
  • Local Institution - 978
    מיקוד מאומת
    סטנפורד, ארצות הברית· הושלם
  • Local Institution - 975
    מיקוד מאומת
    טמפה, ארצות הברית· הושלם
  • Local Institution - 970
    מיקוד מאומת
    שיקגו, ארצות הברית· הושלם
  • Local Institution - 973
    מיקוד מאומת
    בוסטון, ארצות הברית· הושלם
  • Local Institution - 961
    מיקוד מאומת
    דטרויט, ארצות הברית· הושלם
  • Local Institution - 969
    מיקוד מאומת
    ניו יורק, ארצות הברית· הושלם
  • Local Institution - 967
    מיקוד מאומת
    קליבלנד, ארצות הברית· הושלם
  • Local Institution - 972
    מיקוד מאומת
    פילדלפיה, ארצות הברית· הושלם
  • Vanderbilt - Ingram Cancer Center
    מיקוד מאומת
    נאשוויל, ארצות הברית· נמשך
  • The University of Texas - MD Anderson Cancer Center
    מיקוד מאומת
    יוסטון, ארצות הברית· נמשך

שאלות נפוצות

What is the main purpose of this study?

The main purpose is to evaluate the long-term safety of the medicine luspatercept in people who have already been part of another study for this treatment.

מי יכול להשתתף במחקר זה?

Adults aged 18 or over who are currently in or have recently completed another clinical trial for luspatercept and meet specific health criteria, as determined by their doctor.

What kind of conditions is luspatercept used for?

Luspatercept is being studied for blood conditions like Myelodysplastic Syndromes (MDS), Beta-thalassemia, and Myelofibrosis.

כמה זמן אני אהיה במחקר הזה?

This study involves long-term follow-up, which could be for at least 5 years from your first dose of luspatercept or 3 years after your last dose, whichever is longer.

What if I decide I don't want to continue in the study?

You are free to leave the study at any time, for any reason. Your decision will not affect your regular medical care.

כיצד לגלות עוד

מרכז קשר לניסויים קליניים של BMS www.BMSClinicalTrials.com

תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.

מעוניינים להשתתף?

רשום את התעניינותך

שתף את הפרטים שלך וצוות המחקר עבור "A Study to Evaluate Long-term Safety in Participants Who Hav…" ייצרו איתך קשר אם אתה עשוי להיות זכאי. תמיד התייעץ עם הרופא שלך לפני שאתה מסכים להשתתף.

דיון

דיון קהילתי

מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.